Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
We work very hard (sometimes biting off more than we can chew as a company) but it is a very rewarding place to work.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Honesty, passion, determination, innovative, hard-working
Quelle est la meilleure partie de votre programme de rémunération?
stock incentives, salary, bonus, benefits
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
results-oriented, company keeps patients-first, innovative-thinking,
Qu’est-ce qui vous rend le plus heureux au travail?
Seeing the impact we are having on patients' lives
Other Employee Reviews for Karyopharm Therapeutics
×